The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI

Secondary analyses of a previously conducted 1-year randomized controlled trial were performed to assess the application of responder criteria in patients with knee osteoarthritis (OA) using different sets of responder criteria developed by the Osteoarthritis Research Society International (OARSI) (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Osteoarthritis and cartilage 2005-02, Vol.13 (2), p.104-110
Hauptverfasser:	Bellamy, Nicholas, Bell, Mary J., Goldsmith, Charlie H., Pericak, Dan, Walker, Valery, Raynauld, Jean-Pierre, Torrance, George W., Tugwell, Peter, Polisson, Richard
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics - therapeutic use Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Effectiveness Female Humans Hyaluronic Acid - administration & dosage Hyaluronic Acid - analogs & derivatives Hyaluronic Acid - therapeutic use Hylan G-F 20 Injections, Intra-Articular Knee Joint - physiopathology Male Middle Aged Osteoarthritis Osteoarthritis, Knee - drug therapy Osteoarthritis, Knee - physiopathology Pain Measurement - methods Prospective Studies Randomized controlled trial Responder criteria Severity of Illness Index Societies, Medical Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!